Skip to content

M28 Capital Management LP

Follow

13F filer, CIK 1807489, STAMFORD, CT

M28 Capital Management LP reported $36,042,654 across 9 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13.

Accepted , ingested 13F-HR 0000902664-26-004537

Period
2026-09-30
Reported value
$36M
Holdings
9
Top 10 weight
100%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
WVEnew+4,588,284$17M
CRISnew+14,244$12K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
WVEexited-4,588,284-$26.7M
CRISexited-284,889-$149K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000902664-26-004537, largest first. % of portfolio is the value over $36,042,654, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
WVEWAVE LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,588,284 shares 4,588,284$17M47.1%newTimeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,248,250 shares; 2025Q1: 9,248,250 shares; 2025Q2: 9,248,250 shares; 2025Q3: 9,248,250 shares; 2025Q4: 9,248,250 shares; 2026Q1: 9,248,250 shares; 2026Q2: 9,248,250 shares; 2026Q3: 9,248,250 shares 9,248,250$8.05M22.33%0Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 161,600 shares; 2025Q1: 161,600 shares; 2025Q2: 161,600 shares; 2025Q3: 161,600 shares; 2025Q4: 161,600 shares; 2026Q1: 88,354 shares; 2026Q2: 88,354 shares; 2026Q3: 88,354 shares 88,354$4.93M13.67%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 67,400 shares; 2025Q1: 67,400 shares; 2025Q2: 67,400 shares; 2025Q3: 67,400 shares; 2025Q4: 67,400 shares; 2026Q1: 36,851 shares; 2026Q2: 36,851 shares; 2026Q3: 36,851 shares 36,851$2.41M6.69%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 185,100 shares; 2025Q1: 185,100 shares; 2025Q2: 185,100 shares; 2025Q3: 185,100 shares; 2025Q4: 185,100 shares; 2026Q1: 101,203 shares; 2026Q2: 101,203 shares; 2026Q3: 101,203 shares 101,203$1.11M3.07%0Timeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,856,117 shares; 2025Q1: 1,856,117 shares; 2025Q2: 1,856,117 shares; 2025Q3: 1,856,117 shares; 2025Q4: 1,856,117 shares; 2026Q1: 1,856,117 shares; 2026Q2: 1,856,117 shares; 2026Q3: 1,856,117 shares 1,856,117$1.01M2.8%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,019,498 shares; 2025Q1: 1,019,498 shares; 2025Q2: 1,019,498 shares; 2025Q3: 1,019,498 shares; 2025Q4: 1,019,498 shares; 2026Q1: 599,793 shares; 2026Q2: 599,793 shares; 2026Q3: 599,793 shares 599,793$996K2.76%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 385,680 shares; 2025Q1: 385,680 shares; 2025Q2: 385,680 shares; 2025Q3: 385,680 shares; 2025Q4: 385,680 shares; 2026Q1: 210,871 shares; 2026Q2: 210,871 shares; 2026Q3: 210,871 shares 210,871$555K1.54%0Timeline
CRISCURIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 14,244 shares 14,244$12K0.03%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
WVEWAVE LIFE SCIENCES LTD4,588,284$26.7Mshares
CRISCURIS INC284,889$149Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000902664-26-004537 base2026-11-13